BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1176767)

  • 1. Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells.
    Bernard A; Boumsell L; Borsos
    J Immunol; 1975 Oct; 115(4):1091-4. PubMed ID: 1176767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement inhibitor(s) released by leukocytes. I. Pretreatment of sheep erythrocytes with supernatants of mouse spleen and thymus cells inhibit whole complement activity and C2 utilization.
    Bernard A; Boumsell L; Borsos T; Good RA; Day NK
    J Immunol; 1975 Oct; 115(4):1087-90. PubMed ID: 1176766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
    Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
    J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of RNA as a complement inhibitory component in an extract of Ehrlich ascites tumor cells.
    Renk CM; Hoffmann EM
    J Immunol; 1977 Jul; 119(1):263-70. PubMed ID: 326959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system.
    Soter NA; Austen KF; Gigli I
    J Immunol; 1975 Mar; 114(3):928-32. PubMed ID: 1167567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of C1 in rheumatoid synovial fluid, purfied C1 and C1 esterase, by gold compounds.
    Schultz DR; Volanakis JE; Arnold PI; Gottlieb NL; Sakai K; Stroud RM
    Clin Exp Immunol; 1974 Jul; 17(3):395-406. PubMed ID: 4219842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.
    Glovsky MM; Cory M; Alenty A
    Immunology; 1974 Apr; 26(4):819-29. PubMed ID: 4136824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on heterologous antilymphocyte and antithymocyte sera. IV. Further evidence for a preferential effect on antigen-sensitive cells.
    Barth RF
    J Immunol; 1969 Oct; 103(4):648-54. PubMed ID: 4310736
    [No Abstract]   [Full Text] [Related]  

  • 13. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
    Levy NJ; Kasper DL
    J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of concanavalin A on the classical complement pathway.
    Langone JJ; Boyle MD; Borsos T
    J Immunol; 1977 May; 118(5):1622-5. PubMed ID: 858916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of first component of complement (C1) in guinea pig serum by a polysaccharide is prevented by C1 inhibitor.
    Schultz DR; Arnold PI
    J Immunol; 1981 Apr; 126(4):1558-61. PubMed ID: 7204976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro hemolysis of autologous erythrocytes caused by immune murine spleen cells and spherules of the fungus Coccidioides immitis.
    Danley DL; Pappagianis D; Benjamini E
    J Immunol; 1976 Apr; 116(4):970-5. PubMed ID: 1254972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of C3 receptors on lymphoid cells with different complement sources.
    Dierich MP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1974 May; 112(5):1766-73. PubMed ID: 4522461
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of the first component of complement evidence for an internal activation step.
    Loos M; Borsos T; Rapp HJ
    J Immunol; 1972 Mar; 108(3):683-8. PubMed ID: 5011751
    [No Abstract]   [Full Text] [Related]  

  • 19. [A simplified method for the assessment of C1 esterase inhibitor function].
    Deguchi M; Takemura S; Ueda M; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
    Ryumachi; 1990 Jun; 30(3):166-71. PubMed ID: 2244251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium azide inhibition of complement-mediated functions.
    Shaw DR; Shaw MW; Hickman SE; Lamon EW; Griffin FM
    Immunology; 1980 Jan; 39(1):53-6. PubMed ID: 7380463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.